Leveraging Swin Transformer for enhanced diagnosis of Alzheimer's disease using multi-shell diffusion MRI

• URL: http://arxiv.org/abs/2507.09996v1
• Date: Mon, 14 Jul 2025 07:31:40 GMT
• Title: Leveraging Swin Transformer for enhanced diagnosis of Alzheimer's disease using multi-shell diffusion MRI
• Authors: Quentin Dessain, Nicolas Delinte, Bernard Hanseeuw, Laurence Dricot, Benoît Macq,
• Abstract summary: We present a classification pipeline that employs the Swin Transformer, a hierarchical vision transformer model, on multi-shell dMRI data.<n>Key metrics from DTI and NODDI were extracted and projected onto 2D planes to enable transfer learning with ImageNet-pretrained models.<n>We assessed the framework on diagnostic group prediction (cognitively normal, mild cognitive impairment, Alzheimer's disease dementia) and amyloid status classification.
• Score: 1.0439136407307048
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Objective: This study aims to support early diagnosis of Alzheimer's disease and detection of amyloid accumulation by leveraging the microstructural information available in multi-shell diffusion MRI (dMRI) data, using a vision transformer-based deep learning framework. Methods: We present a classification pipeline that employs the Swin Transformer, a hierarchical vision transformer model, on multi-shell dMRI data for the classification of Alzheimer's disease and amyloid presence. Key metrics from DTI and NODDI were extracted and projected onto 2D planes to enable transfer learning with ImageNet-pretrained models. To efficiently adapt the transformer to limited labeled neuroimaging data, we integrated Low-Rank Adaptation. We assessed the framework on diagnostic group prediction (cognitively normal, mild cognitive impairment, Alzheimer's disease dementia) and amyloid status classification. Results: The framework achieved competitive classification results within the scope of multi-shell dMRI-based features, with the best balanced accuracy of 95.2% for distinguishing cognitively normal individuals from those with Alzheimer's disease dementia using NODDI metrics. For amyloid detection, it reached 77.2% balanced accuracy in distinguishing amyloid-positive mild cognitive impairment/Alzheimer's disease dementia subjects from amyloid-negative cognitively normal subjects, and 67.9% for identifying amyloid-positive individuals among cognitively normal subjects. Grad-CAM-based explainability analysis identified clinically relevant brain regions, including the parahippocampal gyrus and hippocampus, as key contributors to model predictions. Conclusion: This study demonstrates the promise of diffusion MRI and transformer-based architectures for early detection of Alzheimer's disease and amyloid pathology, supporting biomarker-driven diagnostics in data-limited biomedical settings.

Related papers

• Flexible and Explainable Graph Analysis for EEG-based Alzheimer's Disease Classification [11.038002513199299]
  Alzheimer's Disease is a progressive neurological disorder that is one of the most common forms of dementia.<n>Recent research has utilized electroencephalography (EEG) data to identify biomarkers that distinguish Alzheimer's Disease patients from healthy individuals.
  arXiv  Detail & Related papers  (2025-04-02T03:29:12Z)
• On the Within-class Variation Issue in Alzheimer's Disease Detection [60.08015780474457]
  Alzheimer's Disease (AD) detection employs machine learning classification models to distinguish between individuals with AD and those without.<n>In this work, we found using a sample score estimator can generate sample-specific soft scores aligning with cognitive scores.<n>We propose two simple yet effective methods: Soft Target Distillation (SoTD) and Instance-level Re-balancing (InRe)
  arXiv  Detail & Related papers  (2024-09-22T02:06:05Z)
• Leveraging Bi-Focal Perspectives and Granular Feature Integration for Accurate Reliable Early Alzheimer's Detection [0.0]
  We propose a novel Granular Feature Integration method to combine information extraction at different scales along with an efficient information flow.<n>We also propose a Bi-Focal Perspective mechanism to highlight the subtle neurofibrillary tangles and amyloid plaques in the MRI scans.<n>Our model achieved an F1-Score of 99.31%, precision of 99.24%, and recall of 99.51%.
  arXiv  Detail & Related papers  (2024-07-15T17:22:16Z)
• AXIAL: Attention-based eXplainability for Interpretable Alzheimer's Localized Diagnosis using 2D CNNs on 3D MRI brain scans [43.06293430764841]
  This study presents an innovative method for Alzheimer's disease diagnosis using 3D MRI designed to enhance the explainability of model decisions. Our approach adopts a soft attention mechanism, enabling 2D CNNs to extract volumetric representations. With voxel-level precision, our method identified which specific areas are being paid attention to, identifying these predominant brain regions.
  arXiv  Detail & Related papers  (2024-07-02T16:44:00Z)
• An interpretable generative multimodal neuroimaging-genomics framework for decoding Alzheimer's disease [13.213387075528017]
  Alzheimer's disease (AD) is the most prevalent form of dementia worldwide, encompassing a prodromal stage known as Mild Cognitive Impairment (MCI)<n>The objective of the work was to capture structural and functional modulations of brain structure and function relying on multimodal MRI data and Single Nucleotide Polymorphisms.
  arXiv  Detail & Related papers  (2024-06-19T07:31:47Z)
• A Demographic-Conditioned Variational Autoencoder for fMRI Distribution Sampling and Removal of Confounds [49.34500499203579]
  We create a variational autoencoder (VAE)-based model, DemoVAE, to decorrelate fMRI features from demographics. We generate high-quality synthetic fMRI data based on user-supplied demographics.
  arXiv  Detail & Related papers  (2024-05-13T17:49:20Z)
• Tensor-Based Multi-Modality Feature Selection and Regression for Alzheimer's Disease Diagnosis [25.958167380664083]
  We propose a novel tensor-based multi-modality feature selection and regression method for diagnosis and biomarker identification of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) We present the practical advantages of our method for the analysis of ADNI data using three imaging modalities.
  arXiv  Detail & Related papers  (2022-09-23T02:17:27Z)
• Morphological feature visualization of Alzheimer's disease via Multidirectional Perception GAN [40.50404819220093]
  A novel Multidirectional Perception Generative Adversarial Network (MP-GAN) is proposed to visualize the morphological features indicating the severity of Alzheimer's disease (AD) MP-GAN achieves superior performance compared with the existing methods.
  arXiv  Detail & Related papers  (2021-11-25T03:24:52Z)
• Differential Diagnosis of Frontotemporal Dementia and Alzheimer's Disease using Generative Adversarial Network [0.0]
  Frontotemporal dementia and Alzheimer's disease are two common forms of dementia and are easily misdiagnosed as each other. Differentiating between the two dementia types is crucial for determining disease-specific intervention and treatment. Recent development of Deep-learning-based approaches in the field of medical image computing are delivering some of the best performance for many binary classification tasks.
  arXiv  Detail & Related papers  (2021-09-12T22:40:50Z)
• G-MIND: An End-to-End Multimodal Imaging-Genetics Framework for Biomarker Identification and Disease Classification [49.53651166356737]
  We propose a novel deep neural network architecture to integrate imaging and genetics data, as guided by diagnosis, that provides interpretable biomarkers. We have evaluated our model on a population study of schizophrenia that includes two functional MRI (fMRI) paradigms and Single Nucleotide Polymorphism (SNP) data.
  arXiv  Detail & Related papers  (2021-01-27T19:28:04Z)
• A Graph Gaussian Embedding Method for Predicting Alzheimer's Disease Progression with MEG Brain Networks [59.15734147867412]
  Characterizing the subtle changes of functional brain networks associated with Alzheimer's disease (AD) is important for early diagnosis and prediction of disease progression. We developed a new deep learning method, termed multiple graph Gaussian embedding model (MG2G) We used MG2G to detect the intrinsic latent dimensionality of MEG brain networks, predict the progression of patients with mild cognitive impairment (MCI) to AD, and identify brain regions with network alterations related to MCI.
  arXiv  Detail & Related papers  (2020-05-08T02:29:24Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.